Current Headlines

  1. FDA Clears Neurostimulation Device For Major Depressive Disorder

    The FDA has cleared the MagVita TMS Therapy system for the treatment of Major Depressive Disorder in adult patients who have failed to receive satisfactory improvement from prior antidepressant medication in the current episode. TMS is a non-invasive technique for stimulating neural tissue in the part of the brain implicated in patients suffering from Major Depressive Disorder. 

  2. Abbott Denies Reported $25B Takeover Of St. Jude Medical

    Abbott Laboratories has denied a Financial Times report that it is preparing to purchase medical device maker St. Jude Medical for about $25 billion. However, analysts say that, consistent with its top executive's earlier pronouncements, Abbott still may be looking to acquire companies smaller than St. Jude. 

  3. J&J, PCH Team To Help Healthcare Startups

    Johnson & Johnson has formed a partnership with PCH, a San Francisco hardware specialist, to help startups navigate the tricky waters from prototype to market.  Two subsidiaries of the companies — PCH Access and J&J Innovation — will join to form Hardware for Health, which aims to create customized business solutions for innovative products that address unmet needs in healthcare.

  4. Greatbatch Pays $1.7B For Lake Region Medical

    Greatbatch, Inc. has announced that it will acquire Lake Region Medical for approximately $1.73 billion in cash and stock, a transformative deal that will create one of the largest medical device OEM suppliers in the world serving the cardiac, neuromodulation, vascular, orthopaedics and advanced surgical markets.

  5. GE, Temple University Health Center Ink Risk-Sharing Collaboration

    GE Healthcare has signed a seven-year agreement with the Temple University Health System (TUHS) that is expected to provide the latter’s hospitals with the latest in high-quality radiologic imaging equipment, and to save TUHS over $39 million in operational costs. In the growing trend of risk-sharing collaborations among medtech companies and hospitals, GE is the first device manufacturer that has signed with an academic health system.

  6. FDA Task Force Proposes Coordinated Registries For National Medical Device Evaluation System

    A task force commissioned by the U.S. Food and Drug Administration Center for Devices and Radiologic Health (CDRH) is proposing a national medical device evaluation system based on coordinated registry networks (CRN) that would pool real-world device data from disparate sources into a single reference for patients, physicians, payers, manufacturers, and regulators.

  7. Bristol Instruments Introduces The Fastest Wavelength Measurement For WDM Testing Applications

    Bristol Instruments, Inc. has set a new standard for WDM wavelength testing with the introduction of the 828B Optical Wavelength Meter. The new 828B model provides reliable accuracy at a rate that is 100 times faster than any other system available.

  8. Medtronic Pays $458 Million For Mitral Valve Device Developer Twelve

    Medtronic has announced the acquisition of Twelve, Inc., a privately-held developer of a transcatheter mitral valve replacement (TMVR) device for the treatment of mitral regurgitation. The deal allows Medtronic to keep pace with rivals in the burgeoning transcatheter valve replacement device segment. Medtronic will pay $408 million at closing, plus a $50 million milestone payment, and Twelve will join the Coronary & Structural Heart division within Medtronic's Cardiac and Vascular Group.

  9. FDA Approves Dexcom’s Fully Mobile G5 CGM System

    Five months after the launch of Dexcom’s G4 Mobile Continuous Glucose Monitoring (CGM) System, the FDA has approved Dexcom’s newest model, the G5, which boasts a transmitter with wireless Bluetooth technology and can communicate with iOS-enabled devices without an additional receiver.  Dexcom announced that patients who had received the G4 model after the beginning of August would be eligible for a free upgrade to the new model.

  10. NuVasive To Significantly Expand Manufacturing

    NuVasive, Inc. has announced that it intends to expand its manufacturing capabilities to meet growing demand for NuVasive’s spine technology and is actively exploring locations to build a new state-of-the-art medical device facility for its spinal implant and instrument manufacturing.  This new facility will support the Company’s efforts to increase the amount of products it internally manufactures, and enhance its focus on operational excellence and efforts to drive accelerated operating margin expansion.

Newsletter Signup
Get the latest medical device industry news, insights, and analysis delivered to your inbox.
By clicking Sign Me Up, you agree to our Terms and that you have read our Privacy Policy.